Table 3.
Mean CARES sexual interest and sexual dysfunction scores accounting for interaction between tamoxifen and amenorrhea
| N | Mean CARES sexual interest a,b (n=461) | N | Mean CARES sexual dysfunction a,b (n=386) c | |||
|---|---|---|---|---|---|---|
| p-value | p-value | |||||
| 0.0009 | 0.0009 | |||||
| Amenorrhea/Tamoxifen | 134 | 1.31 | 114 | 1.45 | ||
| Amenorrhea/No Tamoxifen | 76 | 1.58 | 58 | 1.82 | ||
| No amenorrhea/Chemotherapy | 164 | 1.20 | 138 | 1.18 | ||
| No amenorrhea/No chemotherapy | 87 | 0.86 | 76 | 1.00 | ||
Abbreviations: CARES, Cancer Rehabilitation Evaluation System
a
Higher mean CARES scores are indicative of greater sexual interest problems (i.e., decreased interest) and sexual dysfunction
b
Adjusted for stage, age, race/ethnicity, partner status, time from diagnosis, and other treatment (surgery and radiation)
c
Sexual dysfunction analysis is restricted to women who reported being sexually active since diagnosis